-
¥面议AAT Bioquest Annexin V-iFluor 700标记 货号20077
-
¥面议AAT Bioquest 重组Annexin V 蛋白 货号20015
-
¥面议AAT Bioquest iFluor 647-PEG12-dUTP *1 mM Tris 缓冲液 货号17043
-
¥面议AAT Bioques iFluor 555-PEG12-dUTP *1 mM TE 缓冲液 货号17042
-
¥面议AAT Bioquest iFluor 488-PEG12-dUTP *1 mM TE 缓冲液 货号17041
-
¥面议AAT Bioquest iFluor 488-dUTP * 1 mM的TE缓冲液* 货号17044
产品参数
Ex (nm) | - | Em (nm) | - |
分子量 | N/A | 溶剂 | DMSO |
存储条件 | 在零下15度以下保存, 避免光照 |
产品概述
产品基本信息
产品名称:2',3'-cGAMP 马来酰亚胺
储存条件:-15℃避光防潮
保质期:12个月
产品物理化学光谱特性
分子量:1156.10
外观:固体
溶剂:DMSO
激发波长(nm):NA
发射波长(nm):NA
产品介绍
2',3'-cGAMP 马来酰亚胺是一种出色的试剂,可将 2',3'-cGAMP 共价结合到含硫醇或硫醇修饰的生物靶标,例如蛋白质、肽和核酸。 2',3'-cGAMP 近年来因其作为癌症和病毒感染等靶点的潜力而受到广泛关注。它已被证明可以免疫系统并增强免疫检查点抑制剂的功效,这是一种癌症免疫疗法。 2',3'-cGAMP(环状 GMP-AMP)是一种环状二核苷酸di二信使分子,在先天免疫系统中起着关重要的作用。它由酶 cGAS(环状 GMP-AMP 合酶)合成,以响应从受损或感染细胞中释放的胞质 DNA。一旦合成,2',3'-cGAMP 就会与衔接蛋白 STING(干扰素基因刺激物)结合并触发下游信号通路,从而产生 I 型干扰素和其他细胞因子,从而导致针对入侵病原体的免疫反应。
溶解方案(溶剂以说明书为准)
0.1 mg | 0.5 mg | 1 mg | 5 mg | 10 mg | |
1 mM | 86.498 µL | 432.489 µL | 864.977 µL | 4.325 mL | 8.65 mL |
5 mM | 17.3 µL | 86.498 µL | 172.995 µL | 864.977 µL | 1.73 mL |
10 mM | 8.65 µL | 43.249 µL | 86.498 µL | 432.489 µL | 864.977 µL |
参考文献
cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
Authors: Mekers, Vera E and Kho, Vera M and Ansems, Marleen and Adema, Gosse J
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2022): 158-167
Novel Poxin Stable cGAMP-Derivatives Are Remarkable STING Agonists.
Authors: Stazzoni, Samuele and Böhmer, Daniel F R and Hernichel, Fabian and Özdemir, Dilara and Pappa, Aikaterini and Drexler, David and Bauernfried, Stefan and Witte, Gregor and Wagner, Mirko and Veth, Simon and Hopfner, Karl-Peter and Hornung, Veit and König, Lars M and Carell, Thomas
Journal: Angewandte Chemie (International ed. in English) (2022): e202207175
Discovery of Non-Nucleotide Small-Molecule STING Agonists via Chemotype Hybridization.
Authors: Cherney, Emily C and Zhang, Liping and Lo, Julian and Huynh, Tram and Wei, Donna and Ahuja, Vijay and Quesnelle, Claude and Schieven, Gary L and Futran, Alan and Locke, Gregory A and Lin, Zeyu and Monereau, Laura and Chaudhry, Charu and Blum, Jordan and Li, Sha and Fereshteh, Mark and Li-Wang, Bifang and Gangwar, Sanjeev and Pan, Chin and Chong, Colin and Zhu, Xiao and Posy, Shana L and Sack, John S and Zhang, Ping and Ruzanov, Max and Harner, Mary and Akhtar, Fahad and Schroeder, Gretchen M and Vite, Gregory and Fink, Brian
Journal: Journal of medicinal chemistry (2022): 3518-3538
Catalytic asymmetric and stereodivergent oligonucleotide synthesis.
Authors: Featherston, Aaron L and Kwon, Yongseok and Pompeo, Matthew M and Engl, Oliver D and Leahy, David K and Miller, Scott J
Journal: Science (New York, N.Y.) (2021): 702-707
Crystal structures of human ENPP1 in apo and bound forms.
Authors: Dennis, Matthew L and Newman, Janet and Dolezal, Olan and Hattarki, Meghan and Surjadi, Regina N and Nuttall, Stewart D and Pham, Tam and Nebl, Tom and Camerino, Michelle and Khoo, Poh Sim and Monahan, Brendon J and Peat, Thomas S
Journal: Acta crystallographica. Section D, Structural biology (2020): 889-898
STING Activation and its Application in Immuno-Oncology.
Authors: Lian, Yiqian and Duffy, Kevin J and Yang, Jingsong
Journal: Current topics in medicinal chemistry (2019): 2205-2227
Cytosolic sensing of immuno-stimulatory DNA, the enemy within.
Authors: Dhanwani, Rekha and Takahashi, Mariko and Sharma, Sonia
Journal: Current opinion in immunology (2018): 82-87
Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
Authors: Iurescia, Sandra and Fioretti, Daniela and Rinaldi, Monica
Journal: Recent patents on anti-cancer drug discovery (2018): 2-17
Trafficking-Mediated STING Degradation Requires Sorting to Acidified Endolysosomes and Can Be Targeted to Enhance Anti-tumor Response.
Authors: Gonugunta, Vijay K and Sakai, Tomomi and Pokatayev, Vladislav and Yang, Kun and Wu, Jianjun and Dobbs, Nicole and Yan, Nan
Journal: Cell reports (2017): 3234-3242
- 西安百萤生物科技有限公司
- 第五晓东 市场部
- 18691576690
- 陕西省西安市草堂镇科技企业加速器二区9-20401
为您精选